Drug and Disease Screening Device Under Development - New Technology

Researchers from the California Institute of Technology (CalTech) and the Institute for Systems Biology are using nanotechnology to develop a device that it is hoped can do 2,000 tests on individual cells. Such a device would be much faster than current gene and protein microarrays used in early medical diagnosis and drug screening.

Called a "nanolab" chip, individual cells flow across the device while nanowire sensors identify genes and proteins and nanomechanical sensors detect protein and gene interactions.

Expectations are that by years end the device will be able to identify a dozen protein or gene signatures in 20 minutes. Within another year they hope to detect up to 50 signatures in less than a minute. Once at that stage they will be quickly able to scale up the device to check one to two thousand signatures and diagnose diseases or screen for drugs almost instantaneously.

Posted 30th October 2003

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.